Researchers from the Wellcome Sanger Institute, the University of Cambridge and collaborators have uncovered the interplay between cancer-driving genetic mutations and inherited genetic variants in a ...

AstraZeneca (AZ) and Merck’s – known as MSD outside the US and Canada – Lynparza (olaparib) has been recommended by the National Institute for Health and Care Excellence (NICE) as part of a ...

The US Food and Drug Administration’s (FDA) Cellular, Tissue and Gene Therapies Advisory Committee have completed its meeting for CRISPR Therapeutics and Vertex Pharmaceuticals’ exagamglogene ...

An international study has identified 11 new gene alterations connected to more aggressive prostate cancer using a simple blood test.

The US government has announced the ten drugs selected for the first round of pricing negotiations under President Biden’s Inflation Reduction Act (IRA). The IRA allows Medicare, the government health ...

Five years ago, the revolution in remote working that has taken place would have been impossible to imagine. When 2020 hit, we had no choice but to change. The technology was in place, but there was ...

The US health department has proposed three new models to help lower the cost of drugs, promote accessibility and improve quality of care for those enrolled in voluntary government health insurance ...

The Healthcare Communications Association (HCA) has collaborated on a new mental health initiative after research revealed that more than 90% of communications professionals experienced poor mental ...

The World Health Organization (WHO) has unveiled plans to establish a tuberculosis (TB) vaccine accelerator council to speed up the licensing and use of effective novel vaccines against the disease.

BioNTech has announced it will acquire UK AI start-up InstaDeep in a deal worth up to £562m, following the company’s initial equity investment as part of InstaDeep’s Series B financing round in ...

A new COVID-19 subvariant, XBB.1.5, is causing concern in the US, where it has been spreading rapidly since December. Data from the US Centers for Disease Control and Prevention (CDC) has estimated ...

Merck & Co – known as MSD outside the US and Canada – and Moderna have announced positive phase 2b trial results investigating the use of their personalised mRNA cancer vaccine, mRNA-4157/V940, in ...